✦ LIBER ✦

Cost-effectiveness of rituximab (MabThera®) in diffuse large B-cell lymphoma in the Netherlands

✍ Scribed by M. T. Groot; P. J. Lugtenburg; J. Hornberger; P. C. Huijgens; C. A. Uyl-de Groot

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN13 COST-EFFECTIVENESS OF RITUXIMAB IN

✍ JH Best; J Hornberger; LF Omnes; B Coiffier 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Cost-Effectiveness Analysis of Rituximab

✍ Jennie H. Best; John Hornberger; Stephen J. Proctor; Louis F. Omnes; Fred Jost 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Rituximab in the treatment of diffuse la

✍ Bertrand Coiffier 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Use of rituximab in diffuse large B-cell

✍ Christian Gisselbrecht 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Cost-Effectiveness Analysis of the Addit

✍ Felicetto Ferrara, Dr Roberto Ravasio 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

PO37 Rituximab maintenance therapy in di

✍ S. Trajkova; I. Panovska-Stavridis; A. Stojanovik; D. Dükovski; L. Cevreska 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB